Gilead Sciences, Inc. is an American biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. The company’s primary focus is on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza. Gilead also has a growing presence in oncology and inflammatory diseases. The company operates in a highly competitive and heavily regulated industry, with significant investments in research and development to maintain its leadership position.
Classification: Star Biktarvy is a leading product in Gilead’s HIV/AIDS portfolio. Its high market share and significant market growth are driven by its efficacy and convenience as a once-daily single-tablet regimen. Biktarvy faces competition from other antiretroviral therapies but continues to dominate due to its strong clinical profile.
Classification: Cash Cow Truvada has been a cornerstone in HIV treatment and prevention. Despite a high market share, its growth has slowed due to the emergence of newer therapies and gene...
Our BCG tool allows you to fill out the matrix with your own products.
It's like ChatGPT but for your university course. Ask questions about your course material and get instant answers with citations.